Costa Rica vs Japan: Incidence of tuberculosis
Incidence of tuberculosis over time
- Costa Rica
- Japan
How they compare
Japan currently reports 9.8 per 100,000 people against 9.3 per 100,000 people in Costa Rica, a difference of 0.5 per 100,000 people.
That makes Japan's figure about 1.1 times Costa Rica's.
Across all 25 years both countries report, Japan has been ahead every year.
Costa Rica ranks 153rd and Japan ranks 151st of 208 countries.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.3 per 100,000 people | 32.3 per 100,000 people | 12 per 100,000 people | Japan |
| 2010s | 12.01 per 100,000 people | 18.2 per 100,000 people | 6.19 per 100,000 people | Japan |
| 2020s | 9.62 per 100,000 people | 10.5 per 100,000 people | 0.88 per 100,000 people | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Costa Rica or Japan?
- Japan, at 9.8 per 100,000 people against 9.3 per 100,000 people in Costa Rica as of 2024.
- What is the difference in incidence of tuberculosis between Costa Rica and Japan?
- 0.5 per 100,000 people, with Japan ahead.
- How many years of comparable data are there for Costa Rica and Japan?
- 25 years are reported by both, from 2000 to 2024.
- How do Costa Rica and Japan rank globally for incidence of tuberculosis?
- Costa Rica ranks 153rd and Japan ranks 151st of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.